CVE-2025-30698

moderate-risk
Published 2025-04-15

Vulnerability in the Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition product of Oracle Java SE (component: 2D). Supported versions that are affected are Oracle Java SE: 8u441, 8u441-perf, 11.0.26, 17.0.14, 21.0.6, 24; Oracle GraalVM for JDK: 17.0.14, 21.0.6, 24; Oracle GraalVM Enterprise Edition: 20.3.17 and 21.3.13. Difficult to exploit vulnerability allows unauthenticated attacker with network access via multiple protocols to compromise Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition accessible data as well as unauthorized read access to a subset of Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition. Note: This vulnerability applies to Java deployments, typically in clients running sandboxed Java Web Start applications or sandboxed Java applets, that load and run untrusted code (e.g., code that comes from the internet) and rely on the Java sandbox for security. This vulnerability does not apply to Java deployments, typically in servers, that load and run only trusted code (e.g., code installed by an administrator). CVSS 3.1 Base Score 5.6 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:L).

Do I need to act?

-
0.60% chance of exploitation
EPSS score — low exploit probability
-
Not on CISA KEV list
No confirmed active exploitation reported to CISA
?
Patch status unknown
Check vendor advisories for fix availability and mitigation guidance
5
CVSS 5.6/10 Medium
NETWORK / HIGH complexity

Affected Vendors

39
/ 100
moderate-risk
Severity 18/34 · Moderate
Exploitability 2/34 · Minimal
Exposure 19/34 · Moderate